Alnylam Pharmaceuticals
NEWS
The effort was announced last week by the Henri A. Termeer Tribute Committee.
This not the first time Maraganore has tweeted his support for the benefits of immigration.
The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions.
Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.
The drug developed by Alkermes took a lot of flack but proved effective in a recent study.
The company is weeks away from completing its rolling NDA for Patisiran.
Alnylam and Sanofi Genzyme presented positive Phase III results of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy at a conference in France.
JOBS
IN THE PRESS